Evolus (EOLS) EBITDA Margin (QoQ) (2019 - 2026)
Evolus (EOLS) EBITDA Margin (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.39 Bn | 43.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.69 Bn | 40.04 Bn | 2.15 Bn |
| 3 | Zoetis | 32.28 Bn | 30.60 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.98 Bn | 19.32 Bn | 683.80 Mn |
| 6 | Viatris | 18.94 Bn | 18.06 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.94 Bn | 11.41 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Evolus | 550.51 Mn | 505.34 Mn | 57.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 396.00 |
| Mar 31, 2026 | -1,404.00 |
| Dec 31, 2025 | 2,135.00 |
| Sep 30, 2025 | -196.00 |
| Jun 30, 2025 | 743.00 |
| Mar 31, 2025 | -1,921.00 |
| Dec 31, 2024 | 2,240.00 |
| Sep 30, 2024 | -1,382.00 |
| Jun 30, 2024 | 353.00 |
| Mar 31, 2024 | -88.00 |
| Dec 31, 2023 | 1,271.00 |
| Sep 30, 2023 | 377.00 |
| Jun 30, 2023 | -178.00 |
| Mar 31, 2023 | -449.00 |
| Dec 31, 2022 | 2,842.00 |
| Sep 30, 2022 | 465.00 |
| Jun 30, 2022 | -1,189.00 |
| Mar 31, 2022 | 646.00 |
| Dec 31, 2021 | 1,962.00 |
| Sep 30, 2021 | -1,304.00 |